Singapore markets closed

ContraVir Pharmaceuticals, Inc. (CTRVP)

Other OTC . Currency in USD
Add to watchlist
- (-)
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-48,926
-48,926
-42,200
-32,722
-20,354
Depreciation & amortisation
67.131
67.131
77.461
86.073
34.515
Deferred income taxes
-409.022
-409.022
0
-
0
Stock-based compensation
1,340
1,340
2,553
4,669
2,379
Change in working capital
2,971
2,971
3,153
-5,567
1,629
Other working capital
-40,903
-40,903
-34,978
-31,355
-16,253
Other non-cash items
-440
-440
-414.992
2,310
140
Net cash provided by operating activities
-40,889
-40,889
-34,961
-31,224
-16,165
Cash flows from investing activities
Investments in property, plant and equipment
-14.304
-14.304
-16.336
-130.405
-87.983
Net cash used for investing activities
-14.304
-14.304
-14.07
-130.405
-85.789
Cash flows from financing activities
Debt repayment
-
-
0
-176.585
0
Common stock issued
-
-
0
82,154
42,866
Common stock repurchased
0
0
-21,000
0
-
Other financing activities
-
-
-2,000
-
-
Net cash used provided by (used for) financing activities
4,495
4,495
-5,137
81,977
43,055
Net change in cash
-36,403
-36,403
-40,160
50,622
26,804
Cash at beginning of period
51,189
51,189
91,349
40,727
13,923
Cash at end of period
14,786
14,786
51,189
91,349
40,727
Free cash flow
Operating cash flow
-40,889
-40,889
-34,961
-31,224
-16,165
Capital expenditure
-14.304
-14.304
-16.336
-130.405
-87.983
Free cash flow
-40,903
-40,903
-34,978
-31,355
-16,253